FTC Tells 3rd Circ. Wellbutrin Dismissal Misreads Actavis
The Federal Trade Commission on Friday took aim at a Pennsylvania district court's disposal of a pair of suits accusing GlaxoSmithKline PLC of paying generic-drug makers to withhold their versions of...To view the full article, register now.
Already a subscriber? Click here to view full article